Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Research Rheum

ACR/ARHP Annual Meeting 2012: Can Studying Anticitrullinated Protein Antibodies Put Us on Track to Stop RA?

Thomas R. Collins  |  January 1, 2013

Research is needed before therapies involving them can be used in the clinic and finely tailored for maximum benefit

What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

Aryeh Fischer, MD, and Jeff Swigris, DO, MS  |  December 1, 2012

Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
 

Strategic Thinking to Advance Rheumatology in the New Year

Audrey B. Uknis, MD  |  December 1, 2012

One of the first efforts this coming year will be the development of the American College of Rheumatology’s (ACR’s) 2013-2016 strategic plan

Foundation Research Explores Relationship Between RA and Cardiovascular Disease

Staff  |  December 1, 2012

A grant from the Rheumatology Research Foundation has set two physicians on a course to examine how high-density lipoprotein (HDL) cholesterol is different in rheumatoid arthritis patients

Welcome New ACR and ARHP Leaders

Staff  |  December 1, 2012

The American College of Rheumatology (ACR) welcomes the newest members of the ACR board of directors and the Association of Rheumatology Health Professionals (ARHP) executive committee

The ACR Honors Contributions to Rheumatology

Richard Quinn  |  December 1, 2012

The American College of Rheumatology (ACR) recognizes a group of distinguished individuals for their contributions to rheumatology research, education, and patient care

ACR/ARHP Annual Meeting 2012: Spondylarthritis Criteria Changing Landscape of the Disease

Thomas R. Collins  |  December 1, 2012

More finely tuned view of ankylosing spondylitis leads to better treatment, expert says

CORRONA Team Provides Data-Based Tool to Address Rheumatology’s Questions

Gretchen Henkel  |  December 1, 2012

The Consortium of Rheumatology Researchers of North America (CORRONA) patient registry collects a host of treatment and disease indicators for a variety of rheumatic diseases at every physician visit

Therapies Aimed at Immune Cell Progenitors May Be Key to Reducing Post Myocardial Infarction Risk

Lara C. Pullen, PhD  |  November 9, 2012

Researchers have identified hematopoietic stem and progenitor cells that are liberated from bone marrow niches by a myocardial infarction.

Gadolinium Compounds Provide Insights into Pathogenesis of Fibrosing Diseases

Lara C. Pullen, PhD  |  November 9, 2012

Toll-like receptors appear to play an important role in the pathogenesis of fibrotic disorders including nephrogenic systemic fibrosis and systemic sclerosis.

  • « Previous Page
  • 1
  • …
  • 91
  • 92
  • 93
  • 94
  • 95
  • …
  • 127
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences